[Neurotoxicity of amyloid beta proteins].
Hattori
Naoki
N
hattorin@takii.kmu.ac.jp
Kitagawa
Kaori
K
Nakayama
Yasuhisa
Y
Inagaki
Chiyoko
C
D019870:1-Phosphatidylinositol 4-Kinase / Q000502:physiology*; D000544:Alzheimer Disease / Q000188:drug therapy / Q000209:etiology*; D016229:Amyloid beta-Peptides / Q000037:antagonists & inhibitors* / Q000096:biosynthesis / Q000633:toxicity*; D016564:Amyloid beta-Protein Precursor / Q000378:metabolism; D000818:Animals; D001921:Brain / Q000378:metabolism* / Q000473:pathology*; D018118:Chloride Channels / Q000502:physiology; D015195:Drug Design; D006801:Humans; D017774:Long-Term Potentiation; D016874:Neurofibrillary Tangles; D009474:Neurons / Q000378:metabolism / Q000473:pathology*; D010716:Phosphatidylinositols / Q000378:metabolism; D025801:Ubiquitin / Q000502:physiology
D016229:Amyloid beta-Peptides; D016564:Amyloid beta-Protein Precursor; D018118:Chloride Channels; D010716:Phosphatidylinositols; D025801:Ubiquitin; D019870:1-Phosphatidylinositol 4-Kinase